{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-076613","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2024-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.028685+00:00","generated_at":"2026-06-04T08:18:00.647956+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sangamo Therapeutics announces $24M registered direct offering of common stock and warrants","bullets":["Offering includes 24.8M shares, 3.8M pre-funded warrants, and 28.6M purchase warrants at $0.84/unit.","Gross proceeds expected ~$24.0M; closing on or about March 26, 2024.","Placement agents: Barclays Capital Inc. and Cantor Fitzgerald & Co.; 6% cash fee.","Pre-funded warrant exercise price $0.01; purchase warrant exercise price $1.00 with 5.5-year term.","Lock-Up Agreements from directors and officers restrict share sales for a period."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-076613","json":"https://secwatch.observer/filing/0001193125-24-076613.json","markdown":"https://secwatch.observer/filing/0001193125-24-076613.md","text":"https://secwatch.observer/filing/0001193125-24-076613.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000119312524076613/0001193125-24-076613-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000119312524076613/d816036d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:18:00.647956+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}